Ipilimumab

Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Pouyan N. Changizzadeh, Shiva Kumar R. Mukkamalla, Vincent A. Armenio

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 97; DOI: 10.1186/s40425-017-0303-9
Immunotherapy-associated autoimmune hemolytic anemia
Uqba Khan, Farman Ali, Muhammad Siddique Khurram, Awais Zaka, Tarik Hadid

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 15; DOI: 10.1186/s40425-017-0214-9
Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)
Jeanelle King, Javier de la Cruz, Jose Lutzky

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 19; DOI: 10.1186/s40425-017-0224-7
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
Matthew J. Reilley, Ann Bailey, Vivek Subbiah, Filip Janku, Aung Naing, Gerald Falchook, Daniel Karp, Sarina Piha-Paul, Apostolia Tsimberidou, Siqing Fu, JoAnn Lim, Stacie Bean, Allison Bass, Sandra Montez, Luis Vence, Padmanee Sharma, James Allison, Funda Meric-Bernstam, David S. Hong

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 35; DOI: 10.1186/s40425-017-0238-1
Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients
Luc Cabel, Elika Loir, Gwenaelle Gravis, Pernelle Lavaud, Christophe Massard, Laurence Albiges, Giulia Baciarello, Yohann Loriot, Karim Fizazi

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 31; DOI: 10.1186/s40425-017-0232-7
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab
Saskia JAM Santegoets, Anita GM Stam, Sinéad M Lougheed, Helen Gall, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Rik J Scheper, Winald R Gerritsen, Alfons JM van den Eertwegh, Tanja D de Gruijl

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 31; DOI: 10.1186/s40425-014-0031-3
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi, Kristen Spencer, Mary Ruisi, Nageatte Ibrahim, Jason J Luke, John A Thompson, Keisuke Shirai, David Lawson, Heddy Bartell, Ragini Kudchadkar, Ngoc Thi Gunter, Janice M Mehnert, Evan J Lipson

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 33; DOI: 10.1186/s40425-014-0033-1
Opportunistic infections in patients treated with immunotherapy for cancer
Chrisann Kyi, Matthew D Hellmann, Jedd D Wolchok, Paul B Chapman, Michael A Postow

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 19; DOI: 10.1186/2051-1426-2-19
Ipilimumab in patients with melanoma and autoimmune disease
Chrisann Kyi, Richard D Carvajal, Jedd D Wolchok, Michael A Postow

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 35; DOI: 10.1186/s40425-014-0035-z
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
Evan J Lipson, Victor E Velculescu, Theresa S Pritchard, Mark Sausen, Drew M Pardoll, Suzanne L Topalian, Luis A Diaz

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 42; DOI: 10.1186/s40425-014-0042-0

Main menu

Ipilimumab

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Ipilimumab

Pages